Humana Inc (NYSE:HUM)
$ 335.59 0.91 (0.27%) Market Cap: 40.44 Bil Enterprise Value: 47.74 Bil PE Ratio: 20.90 PB Ratio: 2.51 GF Score: 83/100

Humana Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 02:45PM GMT
Release Date Price: $274.45 (+0.49%)
Steven J. James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great. We'll then get started here with our next session. I'm Steven Valiquette, the Barclays health care services analyst. Very pleased to have Humana here in our next session. To my right, we have Bruce Broussard, the company's CEO; and also Amy Smith from Investor Relations is here as well.

So this will be a fireside chat. I've got some questions I'm going to blaze through. I'll touch on policy and elections, maybe a question or 2 on drug rebate, seems to be somewhat topical right now, focus on some Medicare questions as well. We'll also do the ARS, audience response questions as well, maybe somewhere in the middle of this.

Questions & Answers

Steven J. James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Let's just start high level here. First question around just health care policy. Obviously, a lot of talk around Medicare for All. You've had some discussions around this, but just curious to get your thoughts on how Humana

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot